| |
|
|
Session 26
Oral Abstract Presentations Metabolic and Opportunistic Infectious Complications of HIV Disease Thursday 10 am - 12:45 pm Auditorium |
| Moderators: | Grace McComsey Case Western Reserve Univ, Cleveland, OH and Univ of California, San Francisco |
| 10:00 130 | Exposure to HAART Is Associated with an Increased Risk of Myocardial Infarction: The D:A:D Study N. Friis-Møller*1, R. Weber2, A. D’Arminio Monforte3, W. El-Sadr4, P. Reiss5, F. Dabis6, L. Morfeldt7, S. De Wit8, C. Pradier9, G. Calvo10, M. Law11, O. Kirk12, C. Sabin13, J. D. Lundgren1,12 1Copenhagen HIV Programme (CHIP), Hvidovre Univ Hosp, Denmark; 2SHCS, Univ Hosp, Zurich, Switzerland; 3ICONA, L Sacco Hosp, Univ of Milan, Italy; 4Community Prgrms for Clin Res on AIDS, Columbia Univ /Harlem Hosp, New York, NY; 5ATHENA, Academic Med Ctr, Univ of Amsterdam, The Netherlands; 6Aquitaine, Bordeaux Univ Hosp, France; 7HivBivus, Karolinska Hosp, Stockholm, Sweden; 8St Pierre Cohort, C H U Saint-Pierre Hosp, Brussels, Belgium; 9Nice Cohort, CHU Nice Hopital de l'Archet, France; 10BASS, Autonomous Univ of Barcelona, Spain; 11Australian HIV Observational Database, Natl Ctr in HIV Epidemiology and Clin Res, Sydney, Australia; 12EuroSIDA, CHIP, Hvidovre Univ Hosp, Copenhagen, Denmark; and 13Royal Free Ctr for HIV Med and Univ Coll, London, UK |
| 10:15 131 | Carotid Imtima-media Thickness in HIV-infected and Uninfected Adults: ACTG 5078 J. Currier*1, M. Kendall2, K. Henry3, F. Torriani4, S. Storey5, C. Shikuma6, K. Mickelberg7, B. Alston8, M. Basar9, R. Zackin2, H. Hodis10 1Univ of California at Los Angeles; 2Harvard Sch of Public Hlth, Boston, MA; 3Univ of Minnesota, Minneapolis; 4Univ of California at San Diego; 5Univ of Washington, Seattle; 6Univ of Hawaii, Honolulu, HI; 7Univ of Pennsylvania, Philadelphia, PA; 8Natl Inst of Allergy and Infectious Diseases, NIH, Rockville, MD; 9Frontier Sci and Tech Res Fndn, Buffalo, NY; and 10Univ of Southern California at Los Angeles |
| 10:30 132 | Increasing Incidence of Cardiovascular Disease in HIV-infected Persons in Care R. D. Moore*, J. C. Keruly, G. Lucas Johns Hopkins Univ, Baltimore, MD |
| 10:45 133 | Longitudinal Associations between Antiretroviral Treatments and Quantification of Tissue Mitochondrial DNA from Ambulatory Subjects with HIV Infection C. Cherry*1,2, D. Nolan3,4, I. James3,4, S. Mallal3,4, E. McKinnon3,4, M. French3,4, E. Hammond3,4, M. Gahan1,2, J. McArthur5, S. Wesselingh1,2,6 1Monash Univ, Melbourne, Australia; 2The Alfred Hosp, Melbourne, Australia; 3Royal Perth Hosp, Australia; 4Murdoch Univ, Perth, Australia; 5John Hopkins Univ, Baltimore, MD; and 6Burnet Inst, Melbourne, Australia |
| 11:00 134 | Alendronate, Vitamin D, and Calcium for theTreatment of Osteopenia/Osteoporosis Associated with HIV Infection K. Mondy, W. G. Powderly, S. A. Claxton, K. E. Yarasheski, J. S. Stoneman, M. E. Hoffmann, P. Tebas* Washington Univ, St Louis, MO |
| 11:15 135 | Effectiveness of the 23-valent Capsular Polysaccharide Pneumococcal Vaccination in HIV-1 Infected Patients Receiving Highly Active Antiretroviral Therapy C. C. Hung*1, M. Y. Chen1, S. M. Hsieh1, C. F. Hsiao2, W. J. Liu1, W. H. Sheng1 1Natl Taiwan Univ Hosp, Taipei and 2Natl Hlth Res Inst, Taipei, Taiwan |
| 11:30 136 | Use of Antiretroviral Therapy During Treatment of Active Tuberculosis with a Rifabutin-based Regimen W. Burman*1, D. Benator2, A. Vernon3, A. Khan3, W. El-Sadr4, C. Silva5, C. Lahart6, S. Weis7, B. Mangura8, B. King7, M. Weiner9, B. Jones5 1Denver Publ Hlth and Univ of Colorado Hlth Sci Ctr; 2Veterans Admin Med Ctr, Washington, DC; 3CDC, Atlanta, GA; 4Harlem Hosp Ctr and Columbia Univ Coll of Physicians and Surgeons, New York, NY; 5Los Angeles County-Univ Southern California Med Ctr, CA; 6Thomas Street Clin, Houston, TX; 7Univ of North Texas Hlth Sci Ctr, Ft Worth; 8Natl Tuberculosis Ctr and New Jersey Med Sch, Newark, NJ; and 9Audie L Murphy VA Hosp, San Antonio, TX |
| 11:45 137 | Tuberculosis Relapse and Acquired Rifamycin Resistance in HIV-1 Infected Persons Is Associated with Low CD4 Count, But Is Not More Common with Rifabutin than Rifampin R. Nettles*1, D. Mazo2, K. Alwood1,3, R. Gachuhi3, G. Maltas1,3, K. Wendel4, W. Cronin5, W. Bishai1,3, T. Sterling1,3 1Johns Hopkins Univ Sch of Med, Baltimore, MD; 2Sequella Global TB Fndn, Rockville, MD; 3Baltimore City Hlth Dept TB Clin, MD; 4Oklahoma Univ Hlth Sci Ctr, Tulsa; and 5Maryland Dept of Hlth and Mental Hygiene, Baltimore, MD |
| 12:00 138 | To Study the Safety and Antiretroviral Efficacy of Concomitant Use of Rifampicin and Efavirenz in Antiretroviral-naïve Tuberculosis Co-infected HIV-1 Patients in India A. Patel*1, K. Patel1, J. Patel2, N. Shah3, B. Patel4 1Infectious Disease Clin, Ahmedabad, Gujarat, India; 2Adit Diagnostic Ctr, Ahmedabad, India; 3Sterling Hosp, Ahmedabad, India; and 4Shashwat Microbiology, Ahmedabad, India |
| 12:15 139 | Childhood Exposure to Simian Virus 40 (SV40)-contaminated Poliovirus Vaccine and Risk of AIDS-associated Non-Hodgkin's Lymphoma E. A. Engels*1, L. Rodman1, M. Frisch2, J. J. Goedert1, R. J. Biggar1 1Natl Cancer Inst, Rockville, MD and 2Statens Serum Institut, Copenhagen, Denmark |
| 12:30 139lb | Increased Atherosclerotic Progression in Patients with HIV: The Role of Traditional and Immunologic Risk Factors P. Hsue*1, J. Lo1, A. Franklin2, A.F. Bolger1, S.G. Deeks1, D.D. Waters1 1UCSF, SFGH, San Francisco, CA and 2SFGH, San Francisco, CA |